Literature DB >> 19654500

Retroperitoneal lipomatous tumors without cytologic atypia: are they lipomas? A clinicopathologic and molecular study of 19 cases.

Ricardo S Macarenco1, Michele Erickson-Johnson, Xiaoke Wang, Andrew A Folpe, Brian P Rubin, Antonio G Nascimento, Andre M Oliveira.   

Abstract

Most well-differentiated liposarcomas can be readily distinguished from lipomas on histologic grounds alone. However, occasional retroperitoneal lipomatous tumors show no cytologic atypia. To determine whether these tumors are well-differentiated liposarcomas devoid of cytologic atypia or lipomas was the major aim of this investigation. We comprehensively and prospectively studied 19 retroperitoneal adipocytic tumors devoid of cytologic atypia at the cytogenetic and molecular genetic levels. Median patient age was 56 years (range: 36 to 78 y). Median tumor size was 21 cm (range: 8 to 46 cm) and the median weight was 1127 g (range: 173 to 2440 g). All tumors were well-circumscribed and showed no cytologic atypia. Standard cytogenetic analysis demonstrated rearrangements of 12q15 in 4 (of 7) cases. None showed ring or giant marker chromosomes. Fluorescence in situ hybridization failed to identify amplification of MDM2, carboxypeptidase M(CPM), SAS, CDK4, DDIT3, or HMGA2 in all cases. HMGA2 rearrangement was observed in 8 (of 19) cases (42%) and was more common in larger tumors (P=0.046). HMGA2-LPP fusion was seen in only 1 case. All tumors were completely excised. Follow-up information was available from 10 cases (median, 6 mo; range: 1 to 58 mo). No tumor recurred or metastasized. In contrast, a control group of 20 well-differentiated liposarcomas diagnosed during the same time period (matched per year of diagnosis) showed 4 instances of local recurrence. We conclude that this group of retroperitoneal lipomatous tumors shows clinico-pathologic and genetic features more akin to lipomas than well-differentiated liposarcomas. Owing to their apparent rarity, additional studies are necessary to more fully understand their natural biology in this anatomic location.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19654500     DOI: 10.1097/PAS.0b013e3181b278bf

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  5 in total

1.  Fluorescence In Situ Hybridization for MDM2 Amplification as a Routine Ancillary Diagnostic Tool for Suspected Well-Differentiated and Dedifferentiated Liposarcomas: Experience at a Tertiary Center.

Authors:  Khin Thway; Jayson Wang; John Swansbury; Toon Min; Cyril Fisher
Journal:  Sarcoma       Date:  2015-02-25

2.  Liposarcoma masquerading as an inflammatory pseudotumor: a case report.

Authors:  Jessica J H Reagh; Robert P Eckstein; Christina I Selinger; Justin Evans; Sandra A O'Toole; Anthony J Gill
Journal:  J Med Case Rep       Date:  2016-03-18

3.  Staged management of giant bilateral perinephric adipocytic neoplasms.

Authors:  Aileen Grace P Arriola; Edmund K Bartlett; Paul J Zhang; Kumarasen Cooper; Ali Naji; Robert E Roses
Journal:  Clin Case Rep       Date:  2017-03-23

4.  Fatty tumors of the retroperitoneum: Lipoma or well-differentiated liposarcoma. About a case of a giant retroperitoneal liposarcoma.

Authors:  Mokhtar Bibi; Sami Ben Rhouma; Yassine Ouanes; Beya Chelly; Zinet Ghorbel; Ahmed Sellami; Asma Souid; Seif Boukriba; Mohamed Ali Ben Chehida; Yassine Nouira
Journal:  Urol Case Rep       Date:  2018-09-04

5.  Diagnostic Value of MDM2 and DDIT3 Fluorescence In Situ Hybridization in Liposarcoma Classification: A Single-Institution Experience.

Authors:  Junhun Cho; Seung Eun Lee; Yoon-La Choi
Journal:  Korean J Pathol       Date:  2012-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.